The Advisory Committee on Immunization Practices of the CDC has voted to include adolescents and young adults, between 16 and 23 years old, in its recommendation for meningococcal group B vaccination.
The Advisory Committee on Immunization Practices of the CDC has voted to include adolescents and young adults, between 16 and 23 years old, in its recommendation for meningococcal group B vaccination.